abstract |
The present invention relates to the use of antisense oligonucleotides of at least 10 nucleotides in length, at least two of which are LNAs, as inhibitors of TGF-R signalling, containing said antisense oligonucleotides The pharmaceutical composition of and its use for the prevention and treatment of nervous system, neurodegenerative, fibrosis and hyperproliferative diseases. |